Cargando…
Biochemical, Molecular, and Clinical Characterization of Patients With Primary Carnitine Deficiency via Large-Scale Newborn Screening in Xuzhou Area
Background: Primary carnitine deficiency (PCD) is attributed to a variation in the SLC22A5 (OCTN2) gene which encodes the key protein of the carnitine cycle, the OCTN2 carnitine transporter. PCD is typically identified in childhood by either hypoketotic hypoglycemia, or skeletal and cardiac myopathy...
Autores principales: | Zhou, Wei, Li, Huizhong, Huang, Ting, Zhang, Yan, Wang, Chuanxia, Gu, Maosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399307/ https://www.ncbi.nlm.nih.gov/pubmed/30863740 http://dx.doi.org/10.3389/fped.2019.00050 |
Ejemplares similares
-
Quantification of Differential Metabolites in Dried Blood Spots Using Second-Tier Testing for SCADD/IBDD Disorders Based on Large-Scale Newborn Screening in a Chinese Population
por: Zhou, Wei, et al.
Publicado: (2021) -
Newborn Screening for Methylmalonic Acidemia in a Chinese Population: Molecular Genetic Confirmation and Genotype Phenotype Correlations
por: Zhou, Wei, et al.
Publicado: (2019) -
Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening
por: Lin, Yiming, et al.
Publicado: (2021) -
Clinical, biochemical, and molecular genetic characteristics of patients with primary carnitine deficiency identified by newborn screening in Shanghai, China
por: Chang, Siyu, et al.
Publicado: (2022) -
Correction to: Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening
por: Lin, Yiming, et al.
Publicado: (2022)